Erlotinib vs Rabeprazole

Erlotinib vs Rabeprazole: Overview

This comparison examines the pharmacological differences between Erlotinib and Rabeprazole.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Rabeprazole — 1-2 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Rabeprazole — C18H21N3O3S.

Molecular Weight: Erlotinib — 393.4380 g/mol; Rabeprazole — 359.4440 g/mol.

Type: Erlotinib — Small molecule; Rabeprazole — Small molecule.